Your browser doesn't support javascript.
loading
Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.
Flores-Chávez, Alejandra; Brito-Zerón, Pilar; Ng, Wan-Fai; Szántó, Antónia; Rasmussen, Astrid; Priori, Roberta; Baldini, Chiara; Armagan, Berkan; Özkiziltas, Burcugül; Praprotnik, Sonja; Suzuki, Yasunori; Quartuccio, Luca; Hernández-Molina, Gabriela; Inanc, Nevsun; Bartoloni, Elena; Rischmueller, Maureen; Reis-de Oliveira, Fabiola; Fernandes Moça Trevisani, Virginia; Jurcut, Ciprian; Nordmark, Gunnel; Carubbi, Francesco; Hofauer, Benedikt; Valim, Valeria; Pasoto, Sandra G; Retamozo, Soledad; Atzeni, Fabiola; Fonseca-Aizpuru, Eva; López-Dupla, Miguel; Giacomelli, Roberto; Nakamura, Hideki; Akasbi, Miriam; Thompson, Kyle; Fanny Horváth, Ildiko; Farris, A Darise; Simoncelli, Edoardo; Bombardieri, Stefano; Kilic, Levent; Tufan, Abdurrahman; Perdan Pirkmajer, Katja; Fujisawa, Yuhei; De Vita, Salvatore; Abacar, Kerem; Ramos-Casals, Manuel.
Afiliação
  • Flores-Chávez A; Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.
  • Brito-Zerón P; Autoimmune Diseases Unit, Research and Innovation Group in Autoimmune Diseases, Sanitas Digital Hospital, Hospital-CIMA-Centre Mèdic Milenium Balmes Sanitas, Barcelona, Spain.
  • Ng WF; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, and NIHR Biomedical Research Centre & NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Szántó A; Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Hungary.
  • Rasmussen A; Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Priori R; Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, and Saint Camillus International University of Health Science, UniCamillus, Rome, Italy.
  • Baldini C; Rheumatology Unit, University of Pisa, Italy.
  • Armagan B; Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
  • Özkiziltas B; Department of Internal Medicine, Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey.
  • Praprotnik S; Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia.
  • Suzuki Y; Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • Quartuccio L; Division of Rheumatology, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, Udine, Italy.
  • Hernández-Molina G; Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico.
  • Inanc N; Marmara University, School of Medicine, Istanbul, Turkey.
  • Bartoloni E; Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
  • Rischmueller M; Department of Rheumatology, The Queen Elizabeth Hospital, Discipline of Medicine, University of Adelaide, South Australia, Australia.
  • Reis-de Oliveira F; Ribeirao Preto Medical School, University of São Paulo, Brazil.
  • Fernandes Moça Trevisani V; Division of Health Based Evidence, Federal University of São Paulo, Brazil.
  • Jurcut C; Department of Internal Medicine, Carol Davila Central Military Emergency Hospital, Bucharest, Romania.
  • Nordmark G; Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Carubbi F; Internal Medicine and Nephrology Unit, Department of Medicine, ASL Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy.
  • Hofauer B; Otorhinolaryngology, Head and Neck Surgery, Technical University Munich, Germany.
  • Valim V; University Hospital Cassiano Antonio Moraes (Hucam-Ufes/Ebserh), Federal University of Espírito Santo, Brazil.
  • Pasoto SG; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Brazil.
  • Retamozo S; Department of Rheumatology, Hospital Quirón Salud, Barcelona, Spain.
  • Atzeni F; Rheumatology Unit, University of Messina, Italy.
  • Fonseca-Aizpuru E; Department of Internal Medicine, Hospital de Cabueñes, Gijón, Spain.
  • López-Dupla M; Department of Internal Medicine, Hospital Joan XXIII, Tarragona, Spain.
  • Giacomelli R; Fondazione Policlinico Universitario Campus Bio-Medico, Roma, and Research Unit of Immuno-Rheumatology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Italy.
  • Nakamura H; Division of Haematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan.
  • Akasbi M; Department of Internal Medicine, Hospital Infanta Leonor, Madrid, Spain.
  • Thompson K; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, and NIHR Biomedical Research Centre & NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Fanny Horváth I; Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Hungary.
  • Farris AD; Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Simoncelli E; Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, and Saint Camillus International University of Health Science, UniCamillus, Rome, Italy.
  • Bombardieri S; Rheumatology Unit, University of Pisa, Italy.
  • Kilic L; Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
  • Tufan A; Department of Internal Medicine, Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey.
  • Perdan Pirkmajer K; Department of Rheumatology, University Medical Centre, Ljubljana, and Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Slovenia.
  • Fujisawa Y; Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • De Vita S; Division of Rheumatology, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, Udine, Italy.
  • Abacar K; Marmara University, School of Medicine, Istanbul, Turkey.
  • Ramos-Casals M; Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, and Department of Medicine, University of Barcelona, Spain. mramos@clinic.cat.
Clin Exp Rheumatol ; 41(12): 2437-2447, 2023 12.
Article em En | MEDLINE | ID: mdl-38019164
ABSTRACT

OBJECTIVES:

To analyse how the key components at the time of diagnosis of the Sjögren's phenotype (epidemiological profile, sicca symptoms, and systemic disease) can be influenced by the potential exposure to climate-related natural hazards.

METHODS:

For the present study, the following variables were selected for harmonisation and refinement age, sex, country, fulfilment of 2002/2016 criteria items, dry eyes, dry mouth, and overall ESSDAI score. Climate-related hazards per country were defined according to the OECD and included seven climate-related hazard types extreme temperature, extreme precipitation, drought, wildfire, wind threats, river flooding, and coastal flooding. Climatic variables were defined as dichotomous variables according to whether each country is ranked among the ten countries with the most significant exposure.

RESULTS:

After applying data-cleaning techniques and excluding people from countries not included in the OECD climate rankings, the database study analysed 16,042 patients from 23 countries. The disease was diagnosed between 1 and 3 years earlier in people living in countries included among the top 10 worst exposed to extreme precipitation, wildfire, wind threats, river flooding, and coastal flooding. A lower frequency of dry eyes was observed in people living in countries exposed to wind threats, river flooding, and coastal flooding, with a level of statistical association being classified as strong (p<0.0001 for the three variables). The frequency of dry mouth was significantly lower in people living in countries exposed to river flooding (p<0.0001) and coastal flooding (p<0.0001). People living in countries included in the worse climate scenarios for extreme temperature (p<0.0001) and river flooding (p<0.0001) showed a higher mean ESSDAI score in comparison with people living in no-risk countries. In contrast, those living in countries exposed to worse climate scenarios for wind threats (p<0.0001) and coastal flooding (p<0.0001) showed a lower mean ESSDAI score in comparison with people living in no-risk countries.

CONCLUSIONS:

Local exposure to extreme climate-related hazards plays a role in modulating the presentation of Sjögren across countries concerning the age at which the disease is diagnosed, the frequency of dryness, and the degree of systemic activity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes do Olho Seco / Síndrome de Sjogren Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes do Olho Seco / Síndrome de Sjogren Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article